Japan's GHIT invests $6.8 M in product development for Malaria, NTDs and Ebola
BioSpectrum Asia reported this story. We're following it; read the full report below.
More in Health
- Maximum Chemistry topics explained by a child
- Longest duration to spin a plate on the middle finger by a child
- Veterinary upgrade plan notified; Tonca designated super-speciality hospital
- GHIT announces total investment of approx. USD 6.8 mn in product development for malaria, NTDs and other emerging & re-emerging infectious diseases such as Ebola disease
- Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis
- Acute staff shortage hits Tilthai PHC; Residents demands immediate deployment of doctors & nurses